Average Co-Inventor Count = 8.24
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genmab A+s (29 from 107 patents)
2. Biontech Se (12 from 67 patents)
3. H. Lundbeck A/s (11 from 507 patents)
4. Ganmab A/s (1 from 1 patent)
41 patents:
1. 12421319 - Binding agents that bind OX40 (CD134) and method of use thereof to treat disease
2. 12410258 - Antibodies capable of binding to OX40, variants thereof and uses thereof
3. 12351650 - Antibodies binding to fibroblast activation protein alpha and death receptor 4
4. 12077596 - Multispecific antibodies against CD40 and CD137
5. 11970544 - Antibodies
6. 11939388 - Multispecific antibodies against CD40 and CD137
7. 11814437 - Antibodies binding to CD30 and CD3
8. 11814411 - Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)
9. 11542323 - Agents, uses and methods for the treatment of synucleinopathy
10. 11524995 - Agents, uses and methods for the treatment of synucleinopathy
11. 11459395 - Binding agents binding to PD-L1 and CD137 and use thereof
12. 11440966 - Multispecific antibodies against CD40 and CD137
13. 11421024 - Agents, uses and methods for the treatment of synucleinopathy
14. 11261254 - Antibodies
15. 11130819 - Antibodies